| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEMP | Gemphire Therapeutics Inc. | Gullans Steven R. Ph.D. | Interim President & CEO | Feb 08, 2018 | Buy | $7.00 | 71,429 | 500,003 | 930,252 | Feb 12, 2018, 04:31 PM | |
| ALRN | AILERON THERAPEUTICS INC | Gullans Steven R. Ph.D. | 10% Owner | Jul 05, 2017 | Buy | $15.00 | 60,000 | 900,000 | 1,016,100 | Jul 06, 2017, 06:16 PM | |
| GEMP | Gemphire Therapeutics Inc. | Gullans Steven R. Ph.D. | Director | Mar 10, 2017 | Buy | $9.47 | 52,798 | 499,997 | 858,823 | Mar 14, 2017, 05:33 PM | |
| GEMP | Gemphire Therapeutics Inc. | Gullans Steven R. Ph.D. | Director | Aug 10, 2016 | Option Exercise | $8.75 | 806,025 | 7,052,173 | 806,025 | Aug 12, 2016, 01:09 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Gullans Steven R. Ph.D. | Director | May 19, 2014 | Buy | $9.24 | 25,000 | 230,978 | 25,000 | May 21, 2014, 05:26 PM | |
| TTPH | TETRAPHASE PHARMACEUTICALS INC | Gullans Steven R. Ph.D. | Director | Mar 25, 2013 | Buy | $7.00 | 496,121 | 3,472,847 | 1,468,505 | Mar 27, 2013, 08:05 PM |
Menu